“…Most of the cases had squamous cell carcinoma histology, and a small part of cases had adenosquamous carcinoma or urothelial carcinoma with squamous differentiation belonging to pancreas, gallbladder, lung, or bladder (Table S1A and S1B ), but collected regardless of histologic grade or surgical stage. Patients were categorized into common SCCs (SCCs originated from nasopharynx 96 , oral cavity 96 , throat 96 , skin 97 , esophagus 98 , lung 99 , cervix 100 , penis 101 , perineum 102 , and vagina 103 ) and rare SCCs (SCCs originated from thyroid 104 , thymus 105 , breast 106 , pancreas 107 , gallbladder 108 , bladder 109 , and anus 110 ), as evaluated by 4th WHO Classification of Tumors 111 – 118 . Patients were excluded if they had other advanced disease, active second malignancy, or any condition that may influence the outcome evaluation (68 rare SCC patients with no outcome information), such as neoadjuvant treatment with chemotherapy, radiotherapy, or targeted therapy.…”